Literature DB >> 19270687

D2R striatopallidal neurons inhibit both locomotor and drug reward processes.

Pierre F Durieux1, Bertrand Bearzatto, Stefania Guiducci, Thorsten Buch, Ari Waisman, Michele Zoli, Serge N Schiffmann, Alban de Kerchove d'Exaerde.   

Abstract

The specific functions of dopamine D(2) receptor-positive (D(2)R) striatopallidal neurons remain poorly understood. Using a genetic mouse model, we found that ablation of D(2)R neurons in the entire striatum induced hyperlocomotion, whereas ablation in the ventral striatum increased amphetamine conditioned place preference. Thus D(2)R striatopallidal neurons limit both locomotion and, unexpectedly, drug reinforcement.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19270687     DOI: 10.1038/nn.2286

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  15 in total

1.  FACS-array profiling of striatal projection neuron subtypes in juvenile and adult mouse brains.

Authors:  Mary Kay Lobo; Stanislav L Karsten; Michelle Gray; Daniel H Geschwind; X William Yang
Journal:  Nat Neurosci       Date:  2006-02-19       Impact factor: 24.884

Review 2.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

3.  A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration.

Authors:  Thorsten Buch; Frank L Heppner; Christine Tertilt; Tobias J A J Heinen; Marcel Kremer; F Thomas Wunderlich; Steffen Jung; Ari Waisman
Journal:  Nat Methods       Date:  2005-06       Impact factor: 28.547

4.  Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons.

Authors:  S N Schiffmann; J J Vanderhaeghen
Journal:  J Neurosci       Date:  1993-03       Impact factor: 6.167

5.  Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models.

Authors:  Anatol C Kreitzer; Robert C Malenka
Journal:  Nature       Date:  2007-02-08       Impact factor: 49.962

Review 6.  Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system.

Authors:  David W Self
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

7.  Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol.

Authors:  Jesus Bertran-Gonzalez; Clémentine Bosch; Matthieu Maroteaux; Miriam Matamales; Denis Hervé; Emmanuel Valjent; Jean-Antoine Girault
Journal:  J Neurosci       Date:  2008-05-28       Impact factor: 6.167

8.  Conditional ablation of striatal neuronal types containing dopamine D2 receptor disturbs coordination of basal ganglia function.

Authors:  Hiromi Sano; Yasunobu Yasoshima; Natsuki Matsushita; Takeshi Kaneko; Kenji Kohno; Ira Pastan; Kazuto Kobayashi
Journal:  J Neurosci       Date:  2003-10-08       Impact factor: 6.167

9.  A gene expression atlas of the central nervous system based on bacterial artificial chromosomes.

Authors:  Shiaoching Gong; Chen Zheng; Martin L Doughty; Kasia Losos; Nicholas Didkovsky; Uta B Schambra; Norma J Nowak; Alexandra Joyner; Gabrielle Leblanc; Mary E Hatten; Nathaniel Heintz
Journal:  Nature       Date:  2003-10-30       Impact factor: 49.962

Review 10.  Neural systems of reinforcement for drug addiction: from actions to habits to compulsion.

Authors:  Barry J Everitt; Trevor W Robbins
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

View more
  137 in total

1.  Differential regulation of motor control and response to dopaminergic drugs by D1R and D2R neurons in distinct dorsal striatum subregions.

Authors:  Pierre F Durieux; Serge N Schiffmann; Alban de Kerchove d'Exaerde
Journal:  EMBO J       Date:  2011-11-08       Impact factor: 11.598

Review 2.  Striatal mechanisms underlying movement, reinforcement, and punishment.

Authors:  Alexxai V Kravitz; Anatol C Kreitzer
Journal:  Physiology (Bethesda)       Date:  2012-06

3.  Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens.

Authors:  Brad A Grueter; Gabor Brasnjo; Robert C Malenka
Journal:  Nat Neurosci       Date:  2010-11-14       Impact factor: 24.884

Review 4.  Integrating synaptic plasticity and striatal circuit function in addiction.

Authors:  Brad A Grueter; Patrick E Rothwell; Robert C Malenka
Journal:  Curr Opin Neurobiol       Date:  2011-10-12       Impact factor: 6.627

Review 5.  Moonlighting proteins and protein-protein interactions as neurotherapeutic targets in the G protein-coupled receptor field.

Authors:  Kjell Fuxe; Dasiel O Borroto-Escuela; Wilber Romero-Fernandez; Miklós Palkovits; Alexander O Tarakanov; Francisco Ciruela; Luigi F Agnati
Journal:  Neuropsychopharmacology       Date:  2013-09-06       Impact factor: 7.853

Review 6.  Basal ganglia circuit loops, dopamine and motivation: A review and enquiry.

Authors:  Satoshi Ikemoto; Chen Yang; Aaron Tan
Journal:  Behav Brain Res       Date:  2015-04-20       Impact factor: 3.332

7.  Microdialysis and mass spectrometric monitoring of dopamine and enkephalins in the globus pallidus reveal reciprocal interactions that regulate movement.

Authors:  Omar S Mabrouk; Qiang Li; Peng Song; Robert T Kennedy
Journal:  J Neurochem       Date:  2011-05-25       Impact factor: 5.372

Review 8.  Forebrain neurogenesis after focal Ischemic and traumatic brain injury.

Authors:  Steven G Kernie; Jack M Parent
Journal:  Neurobiol Dis       Date:  2009-11-10       Impact factor: 5.996

9.  Cocaine-induced adaptations in D1 and D2 accumbens projection neurons (a dichotomy not necessarily synonymous with direct and indirect pathways).

Authors:  Rachel J Smith; Mary Kay Lobo; Sade Spencer; Peter W Kalivas
Journal:  Curr Opin Neurobiol       Date:  2013-02-18       Impact factor: 6.627

10.  Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling.

Authors:  Julia C Lemos; Danielle M Friend; Alanna R Kaplan; Jung Hoon Shin; Marcelo Rubinstein; Alexxai V Kravitz; Veronica A Alvarez
Journal:  Neuron       Date:  2016-05-18       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.